Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

被引:590
作者
Lee, Heehyoung [3 ]
Herrmann, Andreas [3 ]
Deng, Jie-Hui [3 ]
Kujawski, Maciej [3 ]
Niu, Guilian [2 ]
Li, Zhiwei [2 ]
Forman, Steve [3 ]
Jove, Richard [3 ]
Pardoll, Drew M. [1 ]
Yu, Hua [3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 20892 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33610 USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
基金
美国国家卫生研究院;
关键词
COLITIS-ASSOCIATED CANCER; TRANSCRIPTION FACTOR; LINKS INFLAMMATION; SIGNAL TRANSDUCER; IMMUNE-RESPONSES; GROWTH-FACTOR; CELLS; ACETYLATION; IL-6; PHOSPHORYLATION;
D O I
10.1016/j.ccr.2009.02.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NF-kappa B (ReIA) is constitutively active in many cancers, where it upregulates antiapoptotic and other oncogenic genes. While proinflammatory stimulus-induced NF-kappa B activation involves IKK-dependent nuclear translocation, mechanisms for maintaining constitutive NF-kappa B activity in tumors have not been elucidated. We show here that maintenance of NF-kappa B activity in tumors requires Stat3, which is also frequently constitutively activated in cancer. Stat3 prolongs NF-kappa B nuclear retention through acetyltransferase p300-mediated RelA acetylation, thereby interfering with NF-kappa B nuclear export. Stat3-mediated maintenance of NF-kappa B activity occurs in both cancer cells and tumor-associated hematopoietic cells. Both murine and human cancers display highly acetylated RelA, which is associated with Stat3 activity. This Stat3/NF-kappa B interaction is thus central to both the transformed and nontransformed elements in tumors.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 45 条
  • [1] gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
    Bollrath, Julia
    Phesse, Toby J.
    von Burstin, Vivian A.
    Putoczki, Tracy
    Bennecke, Moritz
    Bateman, Trudie
    Nebelsiek, Tim
    Lundgren-May, Therese
    Canli, Oezge
    Schwitalla, Sarah
    Matthews, Vance
    Schmid, Roland M.
    Kirchner, Thomas
    Arkan, Melek C.
    Ernst, Matthias
    Greten, Florian R.
    [J]. CANCER CELL, 2009, 15 (02) : 91 - 102
  • [2] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [3] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    [J]. IMMUNITY, 1999, 10 (01) : 105 - 115
  • [4] Shaping the nuclear action of NF-κB
    Chen, LF
    Greene, WC
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (05) : 392 - 401
  • [5] Duration of nuclear NF-κB action regulated by reversible acetylation
    Chen, LF
    Fischle, W
    Verdin, E
    Greene, WC
    [J]. SCIENCE, 2001, 293 (5535) : 1653 - 1657
  • [6] Acetylation of ReIA at discrete sites regulates distinct nuclear functions of NF-κB
    Chen, LF
    Mu, YJ
    Greene, WC
    [J]. EMBO JOURNAL, 2002, 21 (23) : 6539 - 6548
  • [7] Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation
    Chen, LF
    Greene, WC
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (09): : 549 - 557
  • [8] NF-κB RelA phosphorylation regulates RelA acetylation
    Chen, LF
    Williams, SA
    Mu, YJ
    Nakano, H
    Duerr, JM
    Buckbinder, L
    Greene, WC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (18) : 7966 - 7975
  • [9] Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer
    Dalwadi, H
    Krysan, K
    Heuze-Vourc'h, N
    Dohadwala, M
    Elashoff, D
    Sharma, S
    Cacalano, N
    Lichtenstein, A
    Dubinett, S
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7674 - 7682
  • [10] Transcription factors as targets for cancer therapy
    Darnell, JE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 740 - 749